EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Biofilm Resilience: Molecular Mechanisms Driving Antibiotic Resistance in Clinical Contexts

Ahmad Almatroudi iD

Biology · 06.02.2025 · 14 (2) · 165

DOI: 10.3390/biology14020165 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 06.02.2025. Verfasst von Ahmad Almatroudi. Beteiligte Einrichtung: Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia. Die Arbeit wurde bisher 232-mal zitiert (Crossref) und nennt 381 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qassim University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Healthcare-associated infections pose a significant global health challenge, negatively impacting patient outcomes and burdening healthcare systems. A major contributing factor to healthcare-associated infections is the formation of biofilms, structured microbial communities encased in a self-produced extracellular polymeric substance matrix. Biofilms are critical in disease etiology and antibiotic resistance, complicating treatment and infection control efforts. Their inherent resistance mechanisms enable them to withstand antibiotic therapies, leading to recurrent infections and increased morbidity. This review explores the development of biofilms and their dual roles in health and disease. It highlights the structural and protective functions of the EPS matrix, which shields microbial populations from immune responses and antimicrobial agents. Key molecular mechanisms of biofilm resistance, including restricted antibiotic penetration, persister cell dormancy, and genetic adaptations, are identified as significant barriers to effective management. Biofilms are implicated in various clinical contexts, including chronic wounds, medical device-associated infections, oral health complications, and surgical site infections. Their prevalence in hospital environments exacerbates infection control challenges and underscores the urgent need for innovative preventive and therapeutic strategies. This review evaluates cutting-edge approaches such as DNase-mediated biofilm disruption, RNAIII-inhibiting peptides, DNABII proteins, bacteriophage therapies, antimicrobial peptides, nanoparticle-based solutions, antimicrobial coatings, and antimicrobial lock therapies. It also examines critical challenges associated with biofilm-related healthcare-associated infections, including diagnostic difficulties, disinfectant resistance, and economic implications. This review emphasizes the need for a multidisciplinary approach and underscores the importance of understanding biofilm dynamics, their role in disease pathogenesis, and the advancements in therapeutic strategies to combat biofilm-associated infections effectively in clinical settings. These insights aim to enhance treatment outcomes and reduce the burden of biofilm-related diseases.

Schlagwörter

Stichwörter der Autor:innen

EPSantibiotic resistancebiofilmmolecular mechanismprevention

Autor:innen und Institutionen

  • Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.

ORCID-Profile: Ahmad Almatroudi

Förderung

  • Qassim University

Zitieren

APA

Almatroudi, A. (2025). Biofilm Resilience: Molecular Mechanisms Driving Antibiotic Resistance in Clinical Contexts. Biology, 14(2), 165. https://doi.org/10.3390/biology14020165

Vancouver

Almatroudi A. Biofilm Resilience: Molecular Mechanisms Driving Antibiotic Resistance in Clinical Contexts. Biology. 2025;14(2):165. doi:10.3390/biology14020165

BibTeX
@article{Almatroudi2025,
  author = {Almatroudi, Ahmad},
  title = {Biofilm Resilience: Molecular Mechanisms Driving Antibiotic Resistance in Clinical Contexts},
  journal = {Biology},
  year = {2025},
  volume = {14},
  number = {2},
  pages = {165},
  doi = {10.3390/biology14020165}
}
Kostenlos starten →